{"id":690166,"date":"2024-03-04T17:36:01","date_gmt":"2024-03-04T17:36:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=690166"},"modified":"2024-03-04T17:36:01","modified_gmt":"2024-03-04T17:36:01","slug":"cardiac-safety-services-market-growth-top-key-players-share-size-and-projections-up-to-2027","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/cardiac-safety-services-market-growth-top-key-players-share-size-and-projections-up-to-2027_690166.html","title":{"rendered":"Cardiac Safety Services Market Growth, Top Key Players, Share, Size, and Projections up to 2027"},"content":{"rendered":"
\n
\"Cardiac<\/a><\/div>\n
\n
Cardiac Safety Services Market in terms of revenue was estimated to be worth $739 million in 2023 and is poised to reach $1,282 million by 2028, growing at a CAGR of 11.6% from 2023 to 2028 according to a new report by MarketsandMarkets\u2122<\/div>\n<\/div>\n<\/div>\n
In the near future, the cardiac safety services industry is poised for significant growth and innovation. As pharmaceutical research continues to advance, the demand for robust cardiac safety assessments throughout drug development pipelines will remain crucial.<\/div>\n

Cardiac Safety Services Market<\/a><\/strong> in terms of revenue was estimated to be worth $739 million in 2023 and is poised to reach $1,282 million by 2028, growing at a CAGR of 11.6% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of this market is driven by rising incidence of cardiovascular diseases, large number of cardiac issue related clinical trials. Additionally, the increasing outsourcing of cardiac safety services leading to expanded adoption of cardiac safety services.<\/p>\n

Download an Illustrative overview: https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=174488627<\/a><\/strong><\/p>\n

The integrated services segment accounted for the largest share, by type in the cardiac safety services market in 2022.<\/strong><\/p>\n

By type, the cardiac safety services market has been further categorized as integrated services and standalone services. The integrated services segment held the largest share of the global cardiac safety services market in 2022. This can be attributed to benefits associated with integrated services. Integrated services offer benefits such as comprehensive data integration and improved data quality. Additionally, these services help enhance and expedite clinical trials in the pharmaceutical and biopharmaceutical development cycle. These advantages make integrated services as preferable option against standalone cardiac safety services.<\/p>\n

The ECG\/ Holter measurement services segment accounted for the largest share of the service type segment in the cardiac safety services market in 2022.<\/strong><\/p>\n

Based on service type, the global cardiac safety services market has been segmented into ECG\/Holter measurement services, blood pressure measurement services, cardiovascular imaging services, thorough QT studies, and other cardiac safety services. The ECG\/ Holter measurement services segment held the largest market share in 2022. The large share of this segment can be attributed to the low cost of ECG\/Holter services and rigorous regulations for drug safety, increasing research & development activities to develop effective and innovative drugs.<\/p>\n

The North America region catered the largest share of the cardiac safety services market in 2022.<\/strong><\/p>\n

The cardiac safety services market in North America has experienced significant growth in recent years, showcasing a robust expansion trajectory, owing to large pharmaceutical & biopharmaceutical industry in the region, the rising R&D expenditure, stringent regulations, and the presence of major providers of cardiac safety services in the US and Canada. Additionally, growth of the North American cardiac safety services market is driven by significant factors such as a multitude of ongoing clinical trials, the expansion of the biosimilars and generics sector, and the increasing adoption of outsourcing preclinical, clinical, and laboratory testing services by pharmaceutical and biopharmaceutical companies.<\/p>\n

Request Sample Pages: https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=174488627<\/a><\/strong><\/p>\n

Cardiac Safety Services Market Dynamics:<\/strong><\/p>\n

Drivers:<\/strong><\/p>\n

    \n
  1. Rising incidence of cardiovascular diseases<\/li>\n<\/ol>\n

    Restraints:<\/strong><\/p>\n

      \n
    1.  Inadequacy of cardiotoxicity testing<\/li>\n<\/ol>\n

      Opportunities:<\/strong><\/p>\n

        \n
      1.  Emergence of new methods to curb cardiotoxicity<\/li>\n<\/ol>\n

        Challenge:<\/strong><\/p>\n

          \n
        1.  High cost of cardiac safety evaluation services<\/li>\n<\/ol>\n

          Key Market Players:<\/strong><\/p>\n

          Key players in the cardiac safety services market include Laboratory Corporation of America Holdings (US), Koninklijke Philips N.V. (Netherlands), Clario (US), Banook Group (France), IQVIA (US), Biotrial (France), Certara (US), Celerion (US), Medpace (US), Ncardia (Netherlands), Richmond Pharmacology (UK), PhysioStim (France), Shanghai Medical (China), Pharmaceutical Product Development, Inc. (US), and SGS S.A. (Switzerland).<\/p>\n

          Get 10% Free Customization on this Report: <\/strong><\/p>\n

          https:\/\/www.marketsandmarkets.com\/requestCustomizationNew.asp?id=174488627<\/a><\/strong><\/p>\n

          Media Contact<\/span>
          Company Name:<\/strong>           MarketsandMarkets\u2122 Research Private Ltd.<\/a>
          Contact Person:<\/strong> Mr. Aashish Mehra
          Email:<\/strong>           Send Email<\/a>
          Phone:<\/strong> 18886006441
          Address:<\/strong>630 Dundee Road Suite 430
          City:<\/strong> Northbrook
          State:<\/strong> IL 60062
          Country:<\/strong> United States
          Website:<\/strong>           https:\/\/www.marketsandmarkets.com\/Market-Reports\/cardiac-safety-services-market-174488627.html<\/a><\/p>\n

          <\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

          Cardiac Safety Services Market in terms of revenue was estimated to be worth $739 million in 2023 and is poised to reach $1,282 million by 2028, growing at a CAGR of 11.6% from 2023 to 2028 according to a new … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406,403,404,416],"tags":[],"class_list":["post-690166","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-UK","category-US","category-World"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/690166","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=690166"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/690166\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=690166"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=690166"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=690166"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}